This is good important work - similar to the stuff about antibodies that's been looked into. Hopefully as lab automation/analysis costs keep coming down it'll b

This is good important work - similar to the stuff about antibodies that's been looked into. Hopefully as lab automation/analysis costs keep coming down it'll become more and more feasible to implement validation/characterization requirements into publication processes and increase reproducibility, and it'll be important to know where we're falling short currently.